Pasithea Therapeutics Corp.

Historical 13F Holders

Symbol
KTTA
CUSIP
70261F202
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 70261F202 since 12/18/2024, largest first.

Filer % of Class Filed
Coastlands Capital LP 13G/A
11.5% 7/1/2026
Event 4/9/2026
Janus Henderson Group PLC 13G 10.0% 12/8/2025
Event 11/28/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A
10.0% 8/14/2026
Event 6/30/2026
Adage Capital Management, L.P. 13G
10.0% 2/12/2026
Event 12/31/2025
Squadron Capital Management LLC 13G/A
9.9% 2/17/2026
Event 12/31/2025
Funicular Funds, LP 13G
7.4% 4/22/2026
Event 4/15/2026
Opaleye Management Inc. 13G/A
6.1% 7/31/2026
Event 6/30/2026
Stonepine Capital Management, LLC 13G
5.8% 6/23/2026
Event 6/17/2026
Ameriprise Financial, Inc. 13G/A
5.4% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Intracoastal Capital LLC 13G
4.99% 5/12/2025
Event 5/6/2025
Armistice Capital, LLC 13G/A
4.99% 5/15/2025
Event 3/31/2025
Orca Capital AG 13G/A 4.9% 5/9/2025
Event 5/7/2025
CVI Investments, Inc. 13G/A
3.8% 2/17/2026
Event 12/31/2025
Lawrence Steinman 13D/A 3.1% 3/6/2025
Event 3/1/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 25 16.8 M $8.66 M
2026 Q1 21 12.8 M $9.52 M
2025 Q4 25 12.9 M $16.6 M
2025 Q3 20 612 k $442 k
2025 Q2 13 301 k $217 k
2025 Q1 9 79.0 k $99.1 k
2024 Q4 8 77.2 k $243 k
2024 Q3 8 9.24 k $49.7 k
2024 Q2 9 30.1 k $152 k
2024 Q1 8 30.2 k $219 k